levodopa has been researched along with adenosine-3',5'-cyclic phosphorothioate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chase, TN; Del Dotto, P; Oh, JD | 1 |
| Bureau, G; Chagniel, L; Cyr, M; Lebel, M | 1 |
2 other study(ies) available for levodopa and adenosine-3',5'-cyclic phosphorothioate
| Article | Year |
|---|---|
Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat.
Topics: Animals; Antiparkinson Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Levodopa; Male; Motor Activity; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Thionucleotides | 1997 |
Striatal inhibition of PKA prevents levodopa-induced behavioural and molecular changes in the hemiparkinsonian rat.
Topics: Animals; Behavior, Animal; Biomarkers; Corpus Striatum; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Gait Disorders, Neurologic; Infusion Pumps, Implantable; Levodopa; Locomotion; Male; Parkinsonian Disorders; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Signal Transduction; Thionucleotides | 2010 |